about
Enteroviruses and type 1 diabetes.CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis.Apportioning Blame: Autoreactive CD4+ and CD8+ T Cells in Type 1 Diabetes.Identification of a naturally processed cytotoxic CD8 T-cell epitope of coxsackievirus B4, presented by HLA-A2.1 and located in the PEVKEK region of the P2C nonstructural protein.Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes.Correction: CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis.Cellular immune activation in Gulf War veterans.Functional assessment of the BMPR2 gene in lymphoblastoid cell lines from Graves' disease patients.Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interest.Human peripheral blood mononuclear cell in vitro system to test the efficacy of food bioactive compounds: Effects of polyunsaturated fatty acids and their relation with BMI.HLA Class II molecules on haplotypes associated with type 1 diabetes exhibit similar patterns of binding affinities for coxsackievirus P2C peptides.Characterization of the T-cell response to coxsackievirus B4: evidence that effector memory cells predominate in patients with type 1 diabetes.Role of the capsid protein VP4 in the plasma-dependent enhancement of the Coxsackievirus B4E2-infection of human peripheral blood cells.Serum dipeptidyl peptidase IV activity and sCD26 concentration in patients with choroidal nevus or uveal melanomaGalectin-1 synthesis in type 1 diabetes by different immune cell types: Reduced synthesis by monocytes and Th1 cellsAutoantibodies to glial fibrillary acid protein and S100β in diabetic patientsTissue-polypeptide-specific antigen levels in diabetic patients with normal and pathological biochemical profilesOral hygiene might prevent cancer3 beta hydroxysteroid dehydrogenase autoantibodies in patients with idiopathic premature ovarian failure target N- and C-terminal epitopesDesign of polymeric nanocapsules to improve their lympho-targeting capacity
P50
Q35597416-EED62507-00C1-4E46-9495-F0F56316D444Q35692539-DE01754B-B7C4-4212-9658-E2E7FFE00BD5Q38771022-78657073-FB46-4430-8E3F-C5C7BEC380EBQ40585877-E61D9674-F9CE-495E-940E-6673A8E5E850Q41680619-77AF6014-26E7-40C0-B097-2F08BFDE0F25Q43237580-D771911D-DDA4-4EA2-91F1-7CFA18D1D0D0Q45333605-D47C5EEC-20B0-4AE0-B8C1-3D10E95A5184Q47562094-71E209FD-5EF4-4498-B5B4-5E6A9423B50BQ50951677-86A0D3FD-93D0-4446-961B-4BE31C884B13Q51311308-D3A31517-74B6-48FB-A10D-0397AE7CEA2FQ51987940-94D41DC4-7039-4492-BB18-DA3F87921385Q52012578-7B6A974E-26BC-4C00-B3F1-1DAD41837A4BQ54447033-9947C330-077C-4FE9-BB35-A9232202F023Q58199144-E8596B90-F772-46A4-BE21-57B0092C8606Q58199156-DBB44616-2AD2-48BC-B72B-E1A763FC5E6BQ58199159-2260E903-0B5C-4EE0-B394-A3962DB83645Q58199168-FDC2C127-D533-4180-A2A8-0A03B52DC432Q58700677-47AB4A3C-DBAE-4069-88D3-166BE7DA6EC4Q77337799-68528123-A3B7-4AB3-8652-312066505C6AQ91160086-5B42913A-7888-4144-A1F2-A21F02C03362
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ruben Varela-Calvino
@ast
Ruben Varela-Calvino
@en
Ruben Varela-Calvino
@es
Ruben Varela-Calvino
@nl
Ruben Varela-Calvino
@sl
type
label
Ruben Varela-Calvino
@ast
Ruben Varela-Calvino
@en
Ruben Varela-Calvino
@es
Ruben Varela-Calvino
@nl
Ruben Varela-Calvino
@sl
prefLabel
Ruben Varela-Calvino
@ast
Ruben Varela-Calvino
@en
Ruben Varela-Calvino
@es
Ruben Varela-Calvino
@nl
Ruben Varela-Calvino
@sl
P106
P1153
6506168976
P21
P31
P496
0000-0002-4978-661X
P569
2000-01-01T00:00:00Z